ACTIVATION OF HUMAN MONOCYTE FUNCTIONS BY TUMOR-NECROSIS-FACTOR - RAPID PRIMING FOR ENHANCED RELEASE OF SUPEROXIDE AND ERYTHROPHAGOCYTOSIS,BUT NO DIRECT TRIGGERING OF SUPEROXIDE RELEASE
S. Kitagawa et al., ACTIVATION OF HUMAN MONOCYTE FUNCTIONS BY TUMOR-NECROSIS-FACTOR - RAPID PRIMING FOR ENHANCED RELEASE OF SUPEROXIDE AND ERYTHROPHAGOCYTOSIS,BUT NO DIRECT TRIGGERING OF SUPEROXIDE RELEASE, Experimental hematology, 24(4), 1996, pp. 559-567
Tumor necrosis factor (TNF), like granulocyte-macrophage colony-stimul
ating factor (GM-CSF), rapidly primed human monocytes for enhanced rel
ease of superoxide (O-2(-)) stimulated by receptor-mediated agonists,
N-formyl-methionyl-leucylphenylalanine (FMLP) and concanavalin A (Con
A), but not by phorbol myristate acetate (PMA), which bypasses the rec
eptors to stimulate the cells. The optimal priming was obtained by pre
treatment of suspended monocytes with 10 U/mL TNF for 10 minutes at 37
degrees C. The potency of the maximal priming effect was TNF > GM-CSF
, and the combined effect of TNF and GM-CSF was greater than that of e
ach cytokine alone. GM-CSF induced an increase in cytoplasmic pH, but
TNF did not. These findings suggest that TNF and GM-CSF activate monoc
ytes through different mechanisms. TNF and GM-CSF by themselves never
triggered O-2(-) release in suspended monocytes or monocytes adherent
to endothelial cells, although both cytokines triggered massive releas
e of O-2(-) in human neutrophils. In addition, TNF and GM-CSF induced
tyrosine phosphorylation of a 42-kD protein in neutrophils but not in
monocytes. These findings suggest that the TNF-receptor- or GM-CSF-rec
eptor-mediated signaling pathway for triggering O-2(-) release is acti
ve in neutrophils but inactive or defective in monocytes. TNF also enh
anced phagocytosis of sialidase-treated autologous erythrocytes by mon
ocytes, and this effect was further potentiated in the presence of aut
ologous fresh serum. The significant enhancement of erythrophagocytosi
s was obtained at 1 U/mL TNF. At this concentration of TNF, the expres
sion of C3bi-receptor (CD11b/CD18) was upregulated. These findings sho
w that TNF rapidly primes human monocytes for enhanced release of O-2(
-) and erythrophagocytosis and suggest that TNF activates monocytes th
rough autocrine or paracrine mechanisms at the inflammatory sites inas
much as TNF is primarily produced by activated monocytes/macrophages.